Skip to Content

UK Edition. Click here for US version.

0.9% W/V SODIUM CHLORIDE INTRAVENOUS INFUSION BP

Active substance(s): SODIUM CHLORIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
Projekt26_Layout 1 10.07.14 12:53 Seite 1

1d0d0d1d0d0d0d1d0
5/13103407/Version2

Patient Information Leaflet
0.9% Sodium Chloride
Intravenous Infusion BP

1d0d0d1d0d0d0d1d0

1d0d0d1d0d0d0d1d0

B. Braun Melsungen AG · D-34209 Melsungen, Germany

Please read this leaflet carefully. It provides a sum- case of doubt, compatibility should be checked
mary of information about the product you may be before use. This medicinal product does not require
about to use or be given by your doctor.
any special storage conditions. Do not use unless
the solution is clear and the ampoule is undamComposition
aged.
Each ampoule
Do not use the product after the expiry date shown
contains:
2 ml
5 ml 10 ml 20 ml
on the product label and carton. Store out of reach
Sodium Chloride
of children.
Ph Eur
0.018 g 0.045 g 0.09 g 0.18 g
Water for
Reporting of side effects
If you get any side effects, talk to your doctor,
Injections
Ph Eur to
2 ml
5 ml 10 ml 20 ml pharmacist or nurse. This includes any possible side
effects not listed in the package leaflet. You can
Electrolytes
mmol/l
also report side effects directly via the Yellow Card
Sodium
154
Scheme at: www.mhra.gov.uk/yellowcard.
Chloride
154
By reporting side effects you can help provide more
Milliosmols/l
308
information on the safety of this medicine.
Use
This product is mainly used as a dissolvent and The product licence holder and manufacturer is
B. Braun Melsungen AG, D-34209 Melsungen,
carrier solution for injectable drugs.
Germany.
Dosage
Legal category POM
As required.
Product Licence Number
Route of administration
03551/0076
By intravenous or subcutaneous injection.

B|BRAUN

1d0d0d1d0d0d0d1d0
Schwarz
148x210 mm
5/13103407/Version2
Lätus: 732
Großbritannien
Font size 9

B. Braun Melsungen AG
D-34209 Melsungen
Germany

1d0d0d1d0d0d0d1d0

1d0d0d1d0d0d0d1d0

What precautions are necessary for using this Date of preparation
July 2014.
product?
If the product is to be administered subcutaneously, then one needs to be aware that any additions
to this solution could render it hypertonic and thus
cause pain to the injection site. This product is
compatible with a wide range of medicaments. In

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide